Nomura US Small Cap Core Equity (SMA) (S:0P0001KPCS)
104.07
+6.92
(+7.12%)
USD |
Jun 30 2026
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of September 09, 2026.
Asset Allocation
| Type | % Net |
|---|
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Ligand Pharmaceuticals, Inc. | 2.01% | 288.73 | 1.10% |
| MYR Group, Inc. | 1.82% | 287.93 | 0.47% |
| Travere Therapeutics, Inc. | 1.77% | 66.03 | 1.15% |
| Arcosa, Inc. | 1.74% | 145.68 | 0.16% |
| Federal Signal Corp. | 1.60% | 118.20 | -0.91% |
| Kaiser Aluminum Corp. | 1.57% | 167.85 | 2.23% |
| Supernus Pharmaceuticals, Inc. | 1.55% | 42.34 | -2.73% |
| Minerals Technologies, Inc. | 1.32% | 70.46 | -1.81% |
| Ultra Clean Holdings, Inc. | 1.30% | 75.65 | 4.45% |
| IMAX Corp. | 1.26% | 52.66 | 1.98% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | -- |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | -- |
| Socially Responsible Fund | -- |